Westfield Capital Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-758,356
| Closed | -$20.4M | – | 256 |
|
|
2022
Q1 | $20.4M | Buy |
758,356
+72,807
| +11% | +$1.95M | 0.13% | 167 |
|
|
2021
Q4 | $32.7M | Sell |
685,549
-250,942
| -27% | -$12M | 0.19% | 146 |
|
|
2021
Q3 | $62.2M | Buy |
936,491
+28,731
| +3% | +$1.91M | 0.38% | 98 |
|
|
2021
Q2 | $70.8M | Buy |
907,760
+494,755
| +120% | +$38.6M | 0.42% | 89 |
|
|
2021
Q1 | $39.1M | Buy |
413,005
+22,038
| +6% | +$2.08M | 0.24% | 132 |
|
|
2020
Q4 | $47.6M | Buy |
390,967
+88,348
| +29% | +$10.8M | 0.28% | 122 |
|
|
2020
Q3 | $26.4M | Buy |
302,619
+46,541
| +18% | +$4.07M | 0.17% | 158 |
|
|
2020
Q2 | $16.5M | Buy |
256,078
+79,657
| +45% | +$5.15M | 0.11% | 182 |
|
|
2020
Q1 | $7.88M | Buy |
+176,421
| New | +$7.88M | 0.07% | 183 |
|
|
2019
Q3 | – | Sell |
-5,500
| Closed | -$224K | – | 260 |
|
|
2019
Q2 | $224K | Buy |
+5,500
| New | +$224K | ﹤0.01% | 242 |
|